Medication 'Ambroxol' syrup - a way of treatment

"Ambroxol" syrup is an expectorant that has mucolytic, secretolitic and secretory effects. The given preparation is issued in vials in capacity on 100 ml. The active substance is ambroxol hydrochloride.

Medication "Ambroxol" syrup helps to increase the production of mucous secretion by the bronchial glands, due to which the sputum is liquefied and becomes more liquid. This drug activates hydrolytic enzymes, so sputum is also becoming less viscous. Also "Ambroxol" syrup acts on the ciliated epithelium, which causes sputum to move faster from the bronchial tree, cough becomes less and the pathogenic flora in sputum does not multiply, inflammation in the tracheobronchial tree stops.

"Ambroxol" syrup instructions for use

The drug is designed to treat both inflammatory and non-inflammatory diseases of the respiratory system, which are characterized by a difficult spitting of phlegm. Such diseases include bronchial asthma, pneumonia, acute and chronic bronchitis, laryngitis, tracheobronchitis, tracheitis, COPD, pharyngitis, obstructive bronchitis and others. Also, the drug is used to treat wet cough.

"Ambroxol" is intended for use by adults and children over twelve years of age. In the first category, the drug is prescribed 10 ml three times a day, this regime is observed for two to three days, and then the dose is reduced to 5 ml and taken also three times a day.

If the age of children from 5 to 12 years, then appoint 5 ml of the drug 2-3 times a day, from 2-5 years, 2.5 ml of Ambroxol.

It is undesirable to take "Ambroxol" syrup in the first period of pregnancy, and in subsequent periods its use is not contraindicated. Although part of the drug also gets into the mother's milk, but in very small doses, that does not harm the baby, so it can be used when breastfeeding.

Contraindications to the use of "Ambroxol" syrup

The drug is not used in the initial period of pregnancy and it can not be taken to people who are sensitive to "Bromgexin" and "Ambroxol".

"Ambroxol" syrup is an expectorant that has mucolytic, secretolitic and secretory effects. The given preparation is issued in vials in capacity on 100 ml. The active substance is ambroxol hydrochloride.

Medication "Ambroxol" syrup helps to increase the production of mucous secretion by the bronchial glands, due to which the sputum is liquefied and becomes more liquid. This drug activates hydrolytic enzymes, so sputum is also becoming less viscous. Also "Ambroxol" syrup acts on the ciliated epithelium, which causes sputum to move faster from the bronchial tree, cough becomes less and the pathogenic flora in sputum does not multiply, inflammation in the tracheobronchial tree stops.

"Ambroxol" syrup instructions for use

The drug is designed to treat both inflammatory and non-inflammatory diseases of the respiratory system, which are characterized by a difficult spitting of phlegm. Such diseases include bronchial asthma, pneumonia, acute and chronic bronchitis, laryngitis, tracheobronchitis, tracheitis, COPD, pharyngitis, obstructive bronchitis and others. Also, the drug is used to treat wet cough.

"Ambroxol" is intended for use by adults and children over twelve years of age. In the first category, the drug is prescribed 10 ml three times a day, this regime is observed for two to three days, and then the dose is reduced to 5 ml and taken also three times a day.

If the age of children from 5 to 12 years, then appoint 5 ml of the drug 2-3 times a day, from 2-5 years, 2.5 ml of Ambroxol.

It is undesirable to take "Ambroxol" syrup in the first period of pregnancy, and in subsequent periods its use is not contraindicated. Although part of the drug also gets into the mother's milk, but in very small doses, that does not harm the baby, so it can be used when breastfeeding.

Contraindications to the use of "Ambroxol" syrup

The drug is not used in the initial period of pregnancy and it can not be taken to people who are sensitive to "Bromgexin" and "Ambroxol".

"Ambroxol" syrup very carefully should be taken to people who have peptic ulcer. Also, this drug can not be used together with antitussive drugs, as this will make sputum removal difficult.

Possible side effects

After the application of Ambroxol, angioedema, skin itching, hives, skin rash, sometimes allergic contact dermatitis and anaphylactic shock may occur . Also, nausea and vomiting, constipation, dry mouth, abdominal pain, diarrhea, and possibly dry airway envelopes may also occur.

Many parents resort to self-treatment, which can significantly worsen the health of their child. If Ambroxol is used incorrectly, then it can harm the child. For example, if the baby is sick with ARVI, which affects the upper respiratory tract, and parents start giving him the drug, which activates the glands of the mucous membranes, then the cough becomes even stronger, and the sputum is even greater. Parents need to know that in the presence of diseases of the upper respiratory tract they are not treated with mucolytics.

"Ambroxol" reviews about the drug

Many patients complain that the drug quickly turns a dry cough into a wet cough, but then there is no complete cessation of it. Other patients argue that taking the drug in tablets and as a syrup simultaneously on the second day brings considerable relief. But most people point out that the use of Ambroxol as part of complex therapy brings good effect and rapid cough relief.